SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience - Quaterly Results

28 May 2024 Evaluate
The March 2024 quarter revenue stood at Rs. 1581.80 millions, up 11.18% as compared to Rs. 1422.70 millions during the corresponding quarter last year.Net profit declined -3.40% to Rs. 369.31 millions from Rs. 382.29 millions.OP of the company witnessed a marginal growth to 576.89 millions from 570.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1581.80 1422.70 11.18 5703.70 4609.38 23.74 5703.70 4609.38 23.74
Other Income 21.85 19.64 11.25 106.35 94.89 12.08 106.35 94.89 12.08
PBIDT 576.89 570.10 1.19 1836.11 1383.87 32.68 1836.11 1383.87 32.68
Interest 6.01 7.14 -15.83 21.10 30.84 -31.58 21.10 30.84 -31.58
PBDT 570.88 562.96 1.41 1815.01 1353.03 34.14 1815.01 1353.03 34.14
Depreciation 39.14 30.07 30.16 158.11 118.15 33.82 158.11 118.15 33.82
PBT 531.74 532.89 -0.22 1656.90 1234.88 34.17 1656.90 1234.88 34.17
TAX 162.43 150.60 7.86 465.76 336.30 38.50 465.76 336.30 38.50
Deferred Tax 72.99 18.53 293.90 94.76 29.49 221.33 94.76 29.49 221.33
PAT 369.31 382.29 -3.40 1191.14 898.58 32.56 1191.14 898.58 32.56
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 36.47 40.07 -8.99 32.19 30.02 7.22 32.19 30.02 7.22

Supriya Lifescience Share Price

636.90 -1.05 (-0.16%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×